Patient and Care Partner Experiences Living With Multiple Myeloma

Overview

This study aims to identify the factors, for example, age, race, sex, education, household income, clinical or other geriatric conditions such as depression, anxiety, or lack of social support that can predict those most likely to experience changes in physical and cognitive function and quality of life. Furthermore, patients and care partners experienced challenges, because of multiple myeloma and its associated treatments, will be studied using semi-structured interviews.

SparkCures ID 1249
Trial Phase Observational Trial
Enrollment 64 Patients
Trial Sponsors
  • UNC Lineberger Comprehensive Cancer Center
NCT Identifier

NCT05276622

CLOSED

This trial has terminated.

Am I Eligible?

The following criteria is a partial list of reasons why patients may or may not be eligible to participate in this clinical trial. Further evaluation with a medical professional will be required to determine full eligibility.

The following criteria is provided for health care professionals.

Inclusion Criteria:

Patients must meet the following inclusion criteria to participate in this study:

  • Aged ≥55
  • New myeloma diagnosis as defined by the International Myeloma Working Group, does not have another non-myeloma plasma cell disorder such as POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder, skin changes) or amyloidosis.
  • Starting systemic treatment.
  • Able to understand and speak in English.
  • Able to provide informed consent to participate.

Care Partners must meet the following inclusion criteria to participate in this study

  • Aged ≥18.
  • Able to understand and speak in English.
  • Able to provide informed consent to participate.
  • Be a care partner for a patient with multiple myeloma and is also enrolled in the assessment portion of this study.
  • Willing and able to participate in semi-structured interviews.

Exclusion Criteria:

  • All participants meeting any of the following exclusion criteria at enrollment will be excluded from the study: Inability to read and speak English.
  • Dementia altered mental status, or any psychiatric condition that would prohibit the understanding or rendering of informed consent.

US Trial Locations

Please visit the ClinicalTrials.gov page for historical site information.

View Centers